Screener
Assembly Biosciences ASMB Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Assembly Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211987
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Other accrued expenses | (5,085) | (4,560) |
| Deferred revenue from a related party | (7,828) | (9,419) |
| Operating lease liabilities | (202) | (146) |
| Net cash used in operating activities | (22,097) | (23,439) |
| Cash flows from investing activities | ||
| Proceeds from maturities of marketable securities | 57,600 | 26,432 |
| Purchases of marketable securities | (62,963) | (19,846) |
| Purchases of property and equipment | (19) | — |
Item 1. Financial Statements
FAQ
- What is Assembly Biosciences's operating cash flow?
- Assembly Biosciences (ASMB) reported operating cash flow of -$22.1M in Q1 2026.
- How has Assembly Biosciences's operating cash flow changed year-over-year?
- Assembly Biosciences's operating cash flow increased by 5.7% year-over-year, from -$23.44M to -$22.1M.
- What is the long-term trend for Assembly Biosciences's operating cash flow?
- Over 3 years (2021 to 2024), Assembly Biosciences's operating cash flow has grown at a -18.2% compound annual growth rate (CAGR), from -$93.4M to -$51.12M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Assembly Biosciences's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude